The outcome of Autologous Stem Cell Transplantation in First Complete Remission Acute Myeloid Leukemia Patients- Single Center Study
| Autor: | Arash Jalali, Fatemeh Ghaffari, Amir Hamdi, Babak Bahar, Masoud Iravani, Seyyedasadollah Mousavi, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Mohammad Jahani |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: | |
| Zdroj: | International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 4, Pp 1-4 (2011) |
| Druh dokumentu: | article |
| ISSN: | 2008-3009 2008-2207 |
| Popis: | Post-remission treatment in patients with acute myeloid leukemia is still controversial. One potent choice for patients with no donor available is autologous stem cell transplantation. The median follow-up period was 18 months and the median age was 26 years old. In the review of 116 recently diagnosed AML patients (except AML- M3) who underwent autologous stem cell transplantation, 72.4% of patients remained alive and 27.6% relapsed. Relapse was the most common causes of death in patients. The one- year OS and DFS of patients was 73.8% and 59.8%, respectively. There was no statistically significant difference between age, sexuality and waiting time from diagnosis to transplantation. For more comprehensive results, longer follow- up is required. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|